Lixte Biotechnology Holdings, Inc.
LIXT
$4.20
$0.143.45%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.89M | 887.20K | 1.38M | 1.04M | 1.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 91.30K | 102.50K | 129.50K | 106.60K | 51.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.45M | -- | -- | -- | -- |
| Total Current Assets | 5.43M | 989.80K | 1.51M | 1.15M | 1.69M |
|
|
|||||
| Total Current Assets | 5.43M | 989.80K | 1.51M | 1.15M | 1.69M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 198.80K | -- | -- | 6.90K |
| Total Assets | 5.43M | 1.19M | 1.51M | 1.15M | 1.70M |
|
|
|||||
| Total Accounts Payable | 123.90K | 82.10K | 112.50K | 55.70K | 72.90K |
| Total Accrued Expenses | 112.00K | 10.00K | -- | 27.50K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 285.50K | 445.00K | 242.60K | 235.10K | 256.10K |
| Total Other Current Liabilities | 285.50K | 445.00K | 242.60K | 235.10K | 256.10K |
| Total Current Liabilities | 521.40K | 537.10K | 355.10K | 318.30K | 329.00K |
|
|
|||||
| Total Current Liabilities | 521.40K | 537.10K | 355.10K | 318.30K | 329.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 521.40K | 537.10K | 355.10K | 318.30K | 329.00K |
|
|
|||||
| Common Stock & APIC | 57.89M | 54.20M | 50.44M | 49.39M | 49.32M |
| Retained Earnings | -55.53M | -53.55M | -52.78M | -52.07M | -51.45M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.36M | 651.50K | -2.34M | -2.67M | -2.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.55M | -- | 3.50M | 3.50M | 3.50M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.55M | -- | 3.50M | 3.50M | 3.50M |
|
|
|||||
| Total Common Equity | 2.36M | 651.50K | -2.34M | -2.67M | -2.13M |
| Total Preferred Equity | 2.55M | -- | 3.50M | 3.50M | 3.50M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.91M | 651.50K | 1.16M | 827.20K | 1.37M |
|
|
|||||